MF
MRVI icon

Magnetar Financial’s Maravai LifeSciences MRVI Stock Holding History

Magnetar Financial’s Portfolio MRVI Stock Details MRVI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$224K Buy
+35,958
New +$155K ﹤0.01% 902
2021
Q4 		– Sell
-7,337
Closed -$360K – 1489
2021
Q3 		$360K Buy
+7,337
New +$358K ﹤0.01% 973

Other funds holding MRVI

GL
GTCR LLC Chicago, Illinois $3.91B AUM 14.64% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
1WCM
12 West Capital Management New York $535M AUM 25.99% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
OAM
Ophir Asset Management Sydney, Australia $1.22B AUM 100.03% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return

Magnetar Financial's MRVI Position: Q2 2026 in Review

Magnetar Financial opened a new position in Maravai LifeSciences (MRVI) in Q2 2026: 35,958 shares worth $224K. The stake represents ﹤0.01% of the portfolio and ranks #902 among its holdings. This is a return to the name: Magnetar Financial previously reported a position in MRVI as recently as Q3 2021.

Magnetar Financial first reported a position in MRVI in Q3 2021 and has held it in 2 quarters since. The position peaked at $360K in Q3 2021. 178 funds tracked by Wall St. Rank hold MRVI as of Q2 2026.

  • Magnetar Financial held 35,958 shares of Maravai LifeSciences worth $224K as of Q2 2026.
  • Maravai LifeSciences was a new Magnetar Financial position in Q2 2026.
  • Maravai LifeSciences made up ﹤0.01% of Magnetar Financial's portfolio in Q2 2026, its #902 holding.
  • Magnetar Financial first reported a position in Maravai LifeSciences in Q3 2021 and has held it in 2 quarters since.
  • Magnetar Financial's Maravai LifeSciences position peaked at $360K in Q3 2021.
  • 178 funds tracked by Wall St. Rank held Maravai LifeSciences as of Q2 2026.

Based on Magnetar Financial's 13F filing for Q2 2026, filed 14 Aug 2026.